139 related articles for article (PubMed ID: 8676340)
1. Bisindolylmaleimides linked to DNA minor groove binding lexitropsins: synthesis, inhibitory activity against topoisomerase I, and biological evaluation.
Xie G; Gupta R; Atchison K; Lown JW
J Med Chem; 1996 Mar; 39(5):1049-55. PubMed ID: 8676340
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
Park HJ; Lee HJ; Lee EJ; Hwang HJ; Shin SH; Suh ME; Kim C; Kim HJ; Seo EK; Lee SK
Biosci Biotechnol Biochem; 2003 Sep; 67(9):1944-9. PubMed ID: 14519980
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.
Wang K; Liu ZZ
J Asian Nat Prod Res; 2014; 16(3):296-303. PubMed ID: 24456252
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
[TBL] [Abstract][Full Text] [Related]
5. Indolocarbazole glycosides in inactive conformations.
Facompré M; Carrasco C; Vezin H; Chisholm JD; Yoburn JC; Van Vranken DL; Bailly C
Chembiochem; 2003 May; 4(5):386-95. PubMed ID: 12740810
[TBL] [Abstract][Full Text] [Related]
6. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
7. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, topoisomerase I inhibitory activity and in vitro cytotoxicity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents.
Zhao R; Guan LL; Oreski B; Lown JW
Anticancer Drug Des; 1998 Mar; 13(2):145-57. PubMed ID: 9524556
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
[TBL] [Abstract][Full Text] [Related]
10. Advances in indolo[2,3-a]carbazole chemistry: design and synthesis of protein kinase C and topoisomerase I inhibitors.
Pindur U; Kim YS; Mehrabani F
Curr Med Chem; 1999 Jan; 6(1):29-69. PubMed ID: 9873114
[TBL] [Abstract][Full Text] [Related]
11. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates.
Gupta R; al-Said NH; Oreski B; Lown JW
Anticancer Drug Des; 1996 Jun; 11(4):325-38. PubMed ID: 8679055
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
15. Rebeccamycin analogues as anti-cancer agents.
Prudhomme M
Eur J Med Chem; 2003 Feb; 38(2):123-40. PubMed ID: 12620658
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of indolopyrrolemaleimides.
Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
[TBL] [Abstract][Full Text] [Related]
17. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
[TBL] [Abstract][Full Text] [Related]
18. Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta.
Faul MM; Gillig JR; Jirousek MR; Ballas LM; Schotten T; Kahl A; Mohr M
Bioorg Med Chem Lett; 2003 Jun; 13(11):1857-9. PubMed ID: 12749884
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
Katoh M; Dodo K; Fujita M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
[TBL] [Abstract][Full Text] [Related]
20. Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation.
Rastogi K; Chang JY; Pan WY; Chen CH; Chou TC; Chen LT; Su TL
J Med Chem; 2002 Sep; 45(20):4485-93. PubMed ID: 12238927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
